Wu Y - Search Results

1

Increased mitophagy protects cochlear hair cells from aminoglycoside-induced damage.

Zhang Y, Fang Q, Wang H, Qi J, Sun S, Liao M, Wu Y, Hu Y, Jiang P, Cheng C, Qian X, Tang M, Cao W, Xiang S, Zhang C, Yang J, Gao X, Ying Z, Chai R. Zhang Y, et al. Among authors: wu y. Autophagy. 2023 Jan;19(1):75-91. doi: 10.1080/15548627.2022.2062872. Epub 2022 Apr 26. Autophagy. 2023. PMID: 35471096 Free PMC article.

2

Tetrandrine Prevents Neomycin-Induced Ototoxicity by Promoting Steroid Biosynthesis.

Zhang Q, Wu Y, Yu Y, Niu Y, Fang Q, Chen X, Qi J, Zhang C, Wu G, Su K, Chai R. Zhang Q, et al. Among authors: wu y, wu g. Front Bioeng Biotechnol. 2022 Apr 20;10:876237. doi: 10.3389/fbioe.2022.876237. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35519614 Free PMC article.

3

Pitavastatin protects against neomycin-induced ototoxicity through inhibition of endoplasmic reticulum stress.

Wu Y, Meng W, Guan M, Zhao X, Zhang C, Fang Q, Zhang Y, Sun Z, Cai M, Huang D, Yang X, Yu Y, Cui Y, He S, Chai R. Wu Y, et al. Front Mol Neurosci. 2022 Aug 3;15:963083. doi: 10.3389/fnmol.2022.963083. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35992197 Free PMC article.

4

Critical role of TPRN rings in the stereocilia for hearing.

Qi J, Tan F, Zhang L, Zhou Y, Zhang Z, Sun Q, Li N, Fang Y, Chen X, Wu Y, Zhong G, Chai R. Qi J, et al. Among authors: wu y. Mol Ther. 2024 Jan 3;32(1):204-217. doi: 10.1016/j.ymthe.2023.11.011. Epub 2023 Nov 11. Mol Ther. 2024. PMID: 37952086

5

Development of Chinese herbal medicine for sensorineural hearing loss.

Wu Y, Zhang J, Liu Q, Miao Z, Chai R, Chen W. Wu Y, et al. Acta Pharm Sin B. 2024 Feb;14(2):455-467. doi: 10.1016/j.apsb.2023.11.001. Epub 2023 Nov 4. Acta Pharm Sin B. 2024. PMID: 38322328 Free PMC article. Review.

6

Superparamagnetic iron oxide nanoparticle regulates microbiota-gut-inner ear axis for hearing protection.

Guo Z, Wu Y, Chen B, Kong M, Xie P, Li Y, Liu D, Chai R, Gu N. Guo Z, et al. Among authors: wu y. Natl Sci Rev. 2024 Mar 18;11(6):nwae100. doi: 10.1093/nsr/nwae100. eCollection 2024 Jun. Natl Sci Rev. 2024. PMID: 38707203 Free PMC article.

7

Ruscogenin attenuates sepsis-induced acute lung injury and pulmonary endothelial barrier dysfunction via TLR4/Src/p120-catenin/VE-cadherin signalling pathway.

Wang Y, Xue L, Wu Y, Zhang J, Dai Y, Li F, Kou J, Zhang Y. Wang Y, et al. Among authors: wu y. J Pharm Pharmacol. 2021 Jun 8;73(7):893-900. doi: 10.1093/jpp/rgaa039. J Pharm Pharmacol. 2021. PMID: 33769524

8

A cancer-specific activatable theranostic nanodrug for enhanced therapeutic efficacy via amplification of oxidative stress.

Yu XA, Lu M, Luo Y, Hu Y, Zhang Y, Xu Z, Gong S, Wu Y, Ma XN, Yu BY, Tian J. Yu XA, et al. Among authors: wu y. Theranostics. 2020 Jan 1;10(1):371-383. doi: 10.7150/thno.39412. eCollection 2020. Theranostics. 2020. PMID: 31903126 Free PMC article.

9

Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212].

Wu Y, Yu X, Wang Y, Huang Y, Tang J, Gong S, Jiang S, Xia Y, Li F, Yu B, Zhang Y, Kou J. Wu Y, et al. Acta Pharm Sin B. 2022 Jul;12(7):3198-3199. doi: 10.1016/j.apsb.2022.04.004. Epub 2022 Apr 8. Acta Pharm Sin B. 2022. PMID: 35865100 Free PMC article.

10

Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling.

Wu Y, Yu X, Wang Y, Huang Y, Tang J, Gong S, Jiang S, Xia Y, Li F, Yu B, Zhang Y, Kou J. Wu Y, et al. Acta Pharm Sin B. 2022 Mar;12(3):1198-1212. doi: 10.1016/j.apsb.2021.09.017. Epub 2021 Sep 22. Acta Pharm Sin B. 2022. PMID: 35530141 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78,389 results

Search Page